Is GT Biopharma Inc (GTBP) a Smart Choice in Biotechnology Friday?

Friday, November 10, 2023 12:15 PM | InvestorsObserver Analysts

Mentioned in this article

Is GT Biopharma Inc (GTBP) a Smart Choice in Biotechnology Friday?

The 38 rating InvestorsObserver gives to GT Biopharma Inc (GTBP) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 37 percent of stocks in the Biotechnology industry, GTBP’s 38 overall rating means the stock scores better than 38 percent of all stocks.

GTBP has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on GTBP!

See Full GTBP Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With GT Biopharma Inc Stock Today?

GT Biopharma Inc (GTBP) stock is unmoved -1.27% while the S&P 500 is up 0.79% as of 11:55 AM on Friday, Nov 10. GTBP is unchanged $0.00 from the previous closing price of $0.25 on volume of 97,370 shares. Over the past year the S&P 500 has risen 10.75% while GTBP is down -88.52%. GTBP lost -$0.29 per share the over the last 12 months. Click Here to get the full Stock Report for GT Biopharma Inc stock.